Ponce, Leopoldo A.
HRN: 03-08-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2026
CEFTRIAXONE 1G (VIAL)
04/13/2026
04/20/2026
IV
2G
OD
MULTINODULAR NON-TOXIC GOITER
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: